City

Boston (1)

New York (1)

Condition

Lobular Carcinoma (2)

Breast Cancer (1)

Ductal Carcinoma in Situ (1)

Fatigue Related to Cancer Treatment (1)

Invasive Breast Cancer (1)

Invasive Breast Cancer (Stage I-III) (1)

Lobular Carcinoma in Situ (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

naltrexone (1)

sugar pill (1)

tissue specimen (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

lobular carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ Trial in Boston (Naltrexone, Sugar

Terminated

Has Results

Invasive Breast Cancer (Stage I-III)
+4 more

Naltrexone
Sugar Pill

Boston, Massachusetts
+1 more

Nov 12, 2021

Molecular Genetic Basis of Invasive Breast Cancer Risk

Completed

Breast Cancer
+2 more

Tissue specimen

New York, New York

Memorial Sloan Kettering Cancer Center

Jun 30, 2021